Business

In this article VRTX Follow your favorite stocksCREATE FREE ACCOUNT A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston on Oct. 23, 2019. Brian Snyder | Reuters Shares of Vertex Pharmaceuticals jumped Wednesday after the company’s painkiller, which is being tested as an alternative to opioids, significantly decreased pain in
0 Comments
SpaceX’s next-generation Starship spacecraft atop its powerful Super Heavy rocket is launched from the company’s Boca Chica launchpad on an uncrewed test flight, near Brownsville, Texas, U.S. November 18, 2023.  Joe Skipper | Reuters The valuation of Elon Musk’s SpaceX hit $180 billion based on an ongoing secondary share sale, CNBC confirmed Wednesday. The company is discussing
0 Comments
In this article NFLX Follow your favorite stocksCREATE FREE ACCOUNT Rege-Jean Page and Phoebe Dynevor star in Netflix’s “Bridgerton.” Netflix Creators rejoice: Netflix is finally revealing viewership statistics about nearly all of its shows and movies. Netflix released its first “What We Watched” report Tuesday, which ranks almost all of its shows and movies by
0 Comments
In this article 7267.T-JP HYUO-GB VOW3-DE Follow your favorite stocksCREATE FREE ACCOUNT United Auto Workers President Shawn Fain during an online broadcast updating union members on negotiations with the Detroit automakers on Oct. 6, 2023. Screenshot DETROIT — The United Auto Workers has filed unfair labor practice charges with the National Labor Relations Board against
0 Comments
In this article PARA Follow your favorite stocksCREATE FREE ACCOUNT The Paramount logo is seen on a building in Los Angeles on Nov. 13, 2023. Nurphoto| Getty Images Paramount Global shares surged Friday following reports from Deadline and Puck News that Skydance and RedBird Capital were exploring potentially taking over the media giant. Paramount shares
0 Comments
In this article VRTX CRSP Follow your favorite stocksCREATE FREE ACCOUNT The U.S. Food and Drug Administration on Friday approved the country’s first gene-editing treatment, Casgevy, for use in patients with sickle cell disease. The approval comes about a decade after the discovery of CRISPR technology for editing human DNA, representing a significant scientific advancement.
0 Comments